Answers are grounded in this paper and cite their sources.
Streptomyces formicae KY5 is a biosynthetically talented strain isolated from the nest of fungus-farming Tetraponera plant ants. S. formicae KY5 is predicted to encode at least 45 biosynthetic gene clusters (BGC), many of which look novel. However, we do not know the products of most of these pathways. One of the BGCs encoded by S. formicae KY5 produces the polyketide antibiotics, the formicamycins. Here we show that in a mutant lacking the formicamycin BGC, a previously cryptic non-ribosomal peptide synthetase (NRPS) pathway is induced that produces the cyclic depsipeptide, LL-A0341 B (LL-B) and the related metabolite, LL-A0341 A (LL-A). Using genetics and comparative metabolomics, we have characterised the genes present in the LL BGC and re-wired the pathway to generate high-level producing strains. This has allowed for detailed structural characterisation and bioactivity testing. We present the first X-ray crystal structure of LL-B which confirms the recently proposed absolute configuration of this natural product, and show it is a potent inhibitor of Gram-positive microorganisms by targeting the membrane phospholipid, cardiolipin. This work shows the importance of continuing to mine the genomes of talented Streptomyces strains, particularly those that are isolated from under-explored environments, as they are a rich source of both new metabolites and new biology.
No takes yet. Share an insight, caveat, or question.
Devine et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: